English
Back
Download
Log in to access Online Inquiry
Back to the Top

$HilleVax (HLVX.US)$ Biomedical investment institution TANG ...

$HilleVax (HLVX.US)$ Biomedical investment institution TANG CAPITAL took advantage of the large decline in stock price to open a position this month, holding 9.5% of the shares. With the support of professional institutions, my venture capital position is also more secure. Hopefully, the clinical trials of HIL-216 multi-valent vaccine will proceed smoothly without any further issues.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
1
See Original
Report
1782 Views
Comment
Sign in to post a comment
  • ⭕北美深蓝 OP : 🌈 The global viral gastroenteritis market is expected to reach $9.5 billion by 2032; 60% of viral gastroenteritis cases are caused by norovirus.

    🌈 HIL-216 is another virus-like granular vaccine against norovirus and has been approved for development outside of China; compared to HIL-214, this vaccine can target more genotypes of norovirus.

🔥美股专业投资者🔥 ⭕主投颠覆性科技与卫健类公司,关注公司护城河宽度与深度,以及能给公司带来高增长的潜在市场规模和现金余额
159
Followers
23
Following
274
Visitors
Follow

Market Insights

Market Hot Picks Market Hot Picks
Unlock Now